Cardiac involvement in sarcoidosis: Evolving concepts in diagnosis and treatment

Seminars in Respiratory and Critical Care Medicine

Volumn 35, Issue 3, 2014, Pages 372-390

  Lynch, Joseph P ^a   Hwang, Jennifer ^a   Bradfield, Jason ^a   Fishbein, Michael ^a   Shivkumar, Kalyanam ^a   Tung, Roderick ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiac; cardiomyopathy; sarcoidosis; ventricular arrhythmias

Indexed keywords

ANTIARRHYTHMIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HYDROXYCHLOROQUINE; METHOTREXATE; GLUCOCORTICOID;

ANGIOCARDIOGRAPHY; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTOPSY; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CAUSE OF DEATH; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GRANULOMATOSIS; HEART ARRHYTHMIA; HEART BLOCK; HEART BLOOD VESSEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TRANSPLANTATION; HEART VENTRICLE ANEURYSM; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MORTALITY; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SARCOIDOSIS; STEROID THERAPY; SUDDEN CARDIAC DEATH; SUDDEN DEATH; TACHYCARDIA; BIOPSY; COMPLICATION; HEART DISEASES; PATHOPHYSIOLOGY; PROCEDURES;

BIOPSY; FLUORODEOXYGLUCOSE F18; GLUCOCORTICOIDS; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904472404     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0034-1376889     Document Type: Article

References (216)

1. Iannuzzi M. C., Rybicki B. A., Teirstein A. S. Sarcoidosis. N Engl J Med: 2007; 357 21 2153 2165
2. Fleming H. Cardiac sarcoidosis. In: James D. G., ed. Sarcoidosis and other granulomatous disorders. New York Marcel Dekker: 1994; 323 334
3. Fleming H. A. Sarcoid heart disease. Br Heart J: 1974; 36 1 54 68
4. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med: 1999; 160 2 736 755
5. Johns C. J., Michele T. M. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore): 1999; 78 2 65 111 (Pubitemid 29153026)
6. Ayyala U. S., Nair A. P., Padilla M. L. Cardiac sarcoidosis. Clin Chest Med: 2008; 29 3 493 508, ix (Pubitemid 351778211)
7. Baughman R. P., Teirstein A. S., Judson M. A., et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med: 2001; 164 10 Pt 1 1885 1889 (Pubitemid 33152325)
8. Nunes H., Freynet O., Naggara N., et al. Cardiac sarcoidosis. Semin Respir Crit Care Med: 2010; 31 4 428 441
9. Kinney E. L., Jackson G. L., Reeves W. C., Zelis R. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients. Am J Med: 1980; 68 4 497 503 (Pubitemid 10141813)
10. Tellier P., Paycha F., Antony I., et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med: 1988; 85 2 189 193
11. Fahy G. J., Marwick T., McCreery C. J., Quigley P. J., Maurer B. J. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest: 1996; 109 1 62 66 (Pubitemid 26017594)
12. Bulkley B. H., Rouleau J. R., Whitaker J. Q., Strauss H. W., Pitt B. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest: 1977; 72 1 27 32 (Pubitemid 8144199)
13. Burstow D. J., Tajik A. J., Bailey K. R., DeRemee R. A., Taliercio C. P. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol: 1989; 63 7 478 482 (Pubitemid 19065326)
14. Perry A., Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med: 1995; 119 2 167 172
15. Roberts W. C., McAllister H. A. Jr, Ferrans V. J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med: 1977; 63 1 86 108 (Pubitemid 8146656)
16. Silverman K. J., Hutchins G. M., Bulkley B. H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation: 1978; 58 6 1204 1211 (Pubitemid 9092005)
17. Virmani R., Bures J. C., Roberts W. C. Cardiac sarcoidosis; a major cause of sudden death in young individuals. Chest: 1980; 77 3 423 428
18. Bagwan I. N., Hooper L. V., Sheppard M. N. Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies. Virchows Arch: 2011; 458 6 671 678
19. Matsui Y., Iwai K., Tachibana T., et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci: 1976; 278 455 469
20. Hamzeh N. Y., Wamboldt F. S., Weinberger H. D. Management of cardiac sarcoidosis in the United States: a Delphi study. Chest: 2012; 141 1 154 162
21. Deng J. C., Baughman R. P., Lynch J. P. III. Cardiac involvement in sarcoidosis. Semin Respir Crit Care Med: 2002; 23 6 513 527 (Pubitemid 36026365)
22. Sharma O. P., Maheshwari A., Thaker K. Myocardial sarcoidosis. Chest: 1993; 103 1 253 258 (Pubitemid 23027268)
23. Longcope W. T., Freiman D. G. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore): 1952; 31 1 1 132
24. Yazaki Y., Isobe M., Hiramitsu S., et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol: 1998; 82 4 537 540 (Pubitemid 28389961)
25. Yazaki Y., Isobe M., Hiroe M., et al. Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol: 2001; 88 9 1006 1010 (Pubitemid 33042612)
26. Sekiguchi M., Yazaki Y., Isobe M., Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther: 1996; 10 5 495 510 (Pubitemid 26375661)
27. Iwai K., Sekiguti M., Hosoda Y., et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis: 1994; 11 1 26 31
28. Sekiguchi M., Numao Y., Imai M., Furuie T., Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J: 1980; 44 4 249 263 (Pubitemid 10058641)
29. Tachibana T., Ohmori F., Ueda E. Clinical study on cardiac sarcoidosis. Ann N Y Acad Sci: 1986; 465 530 542 (Pubitemid 16006593)
30. Gideon N. M., Mannino D. M. Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med: 1996; 100 4 423 427 (Pubitemid 26115197)
31. Morimoto T., Azuma A., Abe S., et al. Epidemiology of sarcoidosis in Japan. Eur Respir J: 2008; 31 2 372 379
32. Iannuzzi M. C. Genetics of sarcoidosis. Semin Respir Crit Care Med: 2007; 28 1 15 21 (Pubitemid 46364270)
33. Takashige N., Naruse T. K., Matsumori A., et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens: 1999; 54 2 191 193 (Pubitemid 29410778)
34. Meyer T., Lauschke J., Ruppert V., Richter A., Pankuweit S., Maisch B. Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology: 2008; 109 2 117 121
35. Valentonyte R., Hampe J., Huse K., et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet: 2005; 37 4 357 364
36. Rybicki B. A., Walewski J. L., Maliarik M. J., Kian H., Iannuzzi M. C.; ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet: 2005; 77 3 491 499 (Pubitemid 41192655)
37. Spagnolo P., Sato H., Grutters J. C., et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens: 2007; 70 3 219 227 (Pubitemid 47106649)
38. Suzuki H., Ota M., Meguro A., et al. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles. Invest Ophthalmol Vis Sci: 2012; 53 11 7109 7115
39. Naruse T. K., Matsuzawa Y., Ota M., et al. HLA-DQB10601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens: 2000; 56 1 52 57 (Pubitemid 30459641)
40. Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med: 2010; 31 4 380 389
41. Lagana S. M., Parwani A. V., Nichols L. C. Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med: 2010; 134 7 1039 1046
42. Chapelon-Abric C., de Zuttere D., Duhaut P., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore): 2004; 83 6 315 334 (Pubitemid 39541109)
43. Tavora F., Cresswell N., Li L., Ripple M., Solomon C., Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol: 2009; 104 4 571 577
44. Stewart R. E., Graham D. M., Godfrey G. W., Friedman H. Z., Das S. K., Shea M. J. Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J: 1988; 115 6 1324 1326
45. Shammas R. L., Movahed A. Sarcoidosis of the heart. Clin Cardiol: 1993; 16 6 462 472 (Pubitemid 23164232)
46. Fleming H. A., Bailey S. M. Sarcoid heart disease. J R Coll Physicians Lond: 1981; 15 4 245 246, 249-253
47. Kim J. S., Judson M. A., Donnino R., et al. Cardiac sarcoidosis. Am Heart J: 2009; 157 1 9 21
48. Aizer A., Stern E. H., Gomes J. A., Teirstein A. S., Eckart R. E., Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol: 2005; 96 2 276 282 (Pubitemid 40978589)
49. Thachil A., Christopher J., Sastry B. K., et al. Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function. J Am Coll Cardiol: 2011; 58 1 48 55
50. Viles-Gonzalez J. F., Pastori L., Fischer A., Wisnivesky J. P., Goldman M. G., Mehta D. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest: 2013; 143 4 1085 1090
51. Zipse M. M., Sauer W. H. Electrophysiologic manifestations of cardiac sarcoidosis. Curr Opin Pulm Med: 2013; 19 5 485 492
52. Yazaki Y., Hongo M., Hiroyoshi Y., et al. Cardiac sarcoidosis in Japan: treatment and prognosis. In: Sekiguchi M., Richardson P. J., eds. Prognosis and Treatment of Cardiomyopathy and Myocarditis. Tokyo University of Tokyo Press: 1994; 341 353
53. Zoneraich S., Gupta M. P., Mehta J., Zoneraich O., Wessely Z. Myocardial sarcoidosis presenting as acute mitral insufficiency. Chest: 1974; 66 4 452 454
54. Desai M. Y., Fallert M. A. Rapidly progressing congestive heart failure due to cardiac sarcoidosis involving papillary muscles: a case report and brief review of the literature. Cardiol Rev: 2003; 11 4 163 168 (Pubitemid 36875449)
55. Raftery E. B., Oakley C. M., Goodwin J. F. Acute subvalvar mitral incompetence. Lancet: 1966; 2 7459 360 365
56. Israel R. H., Poe R. H. Massive pericardial effusion in sarcoidosis. Respiration: 1994; 61 3 176 180 (Pubitemid 24157492)
57. Garrett J., O'Neill H., Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J: 1984; 107 2 394 (Pubitemid 14181933)
58. Shiff A. D., Blatt C. J., Colp C. Recurrent pericardial effusion secondary to sarcoidosis of the pericardium. N Engl J Med: 1969; 281 3 141 143
59. Kinney E., Murthy R., Ascunce G., Donohoe R., Zelis R. Pericardial effusions in sarcoidosis. Chest: 1979; 76 4 476 478 (Pubitemid 10206178)
60. Gregor P., Widimsky P., Sladkova T., Petrikova J., Cervenka V., Visek V. Echocardiography in sarcoidosis. Jpn Heart J: 1984; 25 4 499 508 (Pubitemid 14040406)
61. Verkleeren J. L., Glover M. U., Bloor C., Joswig B. C. Cardiac tamponade secondary to sarcoidosis. Am Heart J: 1983; 106 3 601 603 (Pubitemid 13050640)
62. Angomachalelis N., Hourzamanis A., Salem N., et al. Pericardial effusion concomitant with specific heart muscle disease in systemic sarcoidosis. Postgrad Med J: 1994; 70 01 S8 S12 (Pubitemid 24276903)
63. Barton J. H., Tavora F., Farb A., Li L., Burke A. P. Unusual cardiovascular manifestations of sarcoidosis, a report of three cases: coronary artery aneurysm with myocardial infarction, symptomatic mitral valvular disease, and sudden death from ruptured splenic artery. Cardiovasc Pathol: 2010; 19 4 e119 e123
64. Wait J. L., Movahed A. Anginal chest pain in sarcoidosis. Thorax: 1989; 44 5 391 395 (Pubitemid 19143947)
65. Lam C. S., Tolep K. A., Metke M. P., Glockner J., Cooper L. T. Jr. Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol: 2009; 32 6 E68 E71
66. Ward E. V., Nazari J., Edelman R. R. Coronary artery vasculitis as a presentation of cardiac sarcoidosis. Circulation: 2012; 125 6 e344 e346
67. Jain A., Starek P. J., Delany D. L. Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis. Clin Cardiol: 1990; 13 10 738 740
68. Kosuge H., Noda M., Kakuta T., Kishi Y., Isobe M., Numano F. Left ventricular apical aneurysm in cardiac sarcoidosis. Jpn Heart J: 2001; 42 2 265 269 (Pubitemid 32377500)
69. Marks A., Anderson M. H., Harrison N. K. Ventricular aneurysm secondary to sarcoid disease. Heart: 2004; 90 6 694 (Pubitemid 38668553)
70. Lull R. J., Dunn B. E., Gregoratos G., Cox W. A., Fisher G. W. Ventricular aneurysm due to cardiac sarcoidosis with surgical cure of refractory ventricular tachycardia. Am J Cardiol: 1972; 30 3 282 287
71. Haraki T., Ueda K., Shintani H., Hayashi T., Taki J., Mabuchi H. Spontaneous development of left ventricular aneurysm in a patient with untreated cardiac sarcoidosis. Circ J: 2002; 66 5 519 521
72. Kandolin R., Lehtonen J., Graner M., et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med: 2011; 270 5 461 468
73. Hiraga H., Iwai K., Hiroe M., Omori F., Sekiguchi M., Tachibana T. Guidelines for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases. Tokyo The Japanese Ministry of Health and Ministry: 1993; 23 24
74. Judson M. A., Baughman R. P., Teirstein A. S., Terrin M. L., Yeager H. Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis: 1999; 16 1 75 86 (Pubitemid 29164274)
75. Okayama K., Kurata C., Tawarahara K., Wakabayashi Y., Chida K., Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest: 1995; 107 2 330 334
76. White J. A., Rajchl M., Butler J., Thompson R. T., Prato F. S., Wisenberg G. Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography-magnetic resonance imaging for the diagnosis of cardiac disease. Circulation: 2013; 127 22 e639 e641
77. Patel M. R., Cawley P. J., Heitner J. F., et al. Detection of myocardial damage in patients with sarcoidosis. Circulation: 2009; 120 20 1969 1977
78. Yang Y., Safka K., Graham J. J., et al. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis. J Magn Reson Imaging: 2014; 39 3 609 616
79. Youssef G., Leung E., Mylonas I., et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med: 2012; 53 2 241 248
80. Dubrey S. W., Falk R. H. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis: 2010; 52 4 336 346
81. Akbar J. J., Meyer C. A., Shipley R. T., Vagal A. S. Cardiopulmonary imaging in sarcoidosis. Clin Chest Med: 2008; 29 3 429 443, viii (Pubitemid 351778216)
82. Thunéll M., Bjerle P., Stjernberg N. ECG abnormalities in patients with sarcoidosis. Acta Med Scand: 1983; 213 2 115 118 (Pubitemid 13144391)
83. Gibbons W. J., Levy R. D., Nava S., et al. Subclinical cardiac dysfunction in sarcoidosis. Chest: 1991; 100 1 44 50
84. Schuller J. L., Lowery C. M., Zipse M., et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol: 2011; 16 1 70 76
85. Schuller J. L., Olson M. D., Zipse M. M., et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol: 2011; 22 11 1243 1248
86. Suzuki T., Kanda T., Kubota S., Imai S., Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest: 1994; 106 4 1021 1024 (Pubitemid 24309534)
87. Thunell M., Bjerle P., Karp K., Stjernberg N. Exercise test in patients with sarcoidosis. The importance of repolarization disturbances. Acta Med Scand: 1988; 223 1 69 73 (Pubitemid 18031562)
88. Lewin R. F., Mor R., Spitzer S., Arditti A., Hellman C., Agmon J. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J: 1985; 110 1 Pt 1 116 122 (Pubitemid 16119690)
89. Moiseyev S. V., Kornev B. M., Shatkovsky N. P., Eventov A. Z., Pisareva N. A. Non-invasive diagnosis of cardiac sarcoidosis. Lancet: 1987; 2 8561 739 740 (Pubitemid 17125708)
90. Winters S. L., Cohen M., Greenberg S., et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol: 1991; 18 4 937 943
91. Padilla M. L. Cardiac sarcoidosis. In: Baughman R. P., ed. Sarcoidosis. New York, NY Informa USA: 2010; 515 551
92. Angomachalelis N., Hourzamanis A., Vamvalis C., Gavrielides A. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis. Postgrad Med J: 1992; 68 01 S52 S56
93. Mañá J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med: 1997; 18 4 799 811 (Pubitemid 27525442)
94. Hirose Y., Ishida Y., Hayashida K., et al. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med: 1994; 19 6 522 526 (Pubitemid 24180757)
95. Tawarahara K., Kurata C., Okayama K., Kobayashi A., Yamazaki N. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J: 1992; 124 5 1383 1384
96. Taki J., Nakajima K., Bunko H., Ohguchi M., Tonami N., Hisada K. Cardiac sarcoidosis demonstrated by Tl-201 and Ga-67 SPECT imaging. Clin Nucl Med: 1990; 15 9 636 639 (Pubitemid 20290763)
97. Le Guludec D., Menad F., Faraggi M., Weinmann P., Battesti J. P., Valeyre D. Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest: 1994; 106 6 1675 1682 (Pubitemid 24375125)
98. Tellier P., Valeyre D., Nitenberg A., Foult J. M., Bedig G., Battesti J. P. Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med: 1985; 11 6-7 201 204 (Pubitemid 16233601)
99. Yamamoto N., Gotoh K., Yagi Y., et al. Thallium-201 myocardial SPECT findings at rest in sarcoidosis. Ann Nucl Med: 1993; 7 2 97 103 (Pubitemid 23202194)
100. Haywood L. J., Sharma O. P., Siegel M. E., et al. Detection of myocardial sarcoidosis by thallium 201 imaging. J Natl Med Assoc: 1982; 74 10 959 964 (Pubitemid 13215163)
101. Kurata C., Sakata K., Taguchi T., et al. SPECT imaging with Tl-201 and Ga-67 in myocardial sarcoidosis. Clin Nucl Med: 1990; 15 6 408 411 (Pubitemid 20318290)
102. Tajima T., Naito T., Dohi Y., Miyamae T. Ga-67 and Tl-201 imaging in sarcoidosis involving the myocardium. Clin Nucl Med: 1981; 6 3 120 121 (Pubitemid 11154096)
103. Nagatomo Y., Imamura T., Koiwaya Y., et al. Thallium-201 and gallium-67 myocardial scintigraphy for the evaluation of sarcoid involvement. Clin Nucl Med: 1987; 12 4 335 336 (Pubitemid 17057328)
104. Forman M. B., Sandler M. P., Sacks G. A., Kronenberg M. W., Powers T. A. Radionuclide imaging in myocardial sarcoidosis. Demonstration of myocardial uptake of technetium pyrophosphate99m and gallium. Chest: 1983; 83 3 578 580 (Pubitemid 13156515)
105. Eguchi M., Tsuchihashi K., Hotta D., et al. Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology: 2000; 94 3 193 199 (Pubitemid 32250150)
106. Kaminaga T., Takeshita T., Yamauchi T., Kawamura H., Yasuda M. The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol: 2004; 94 1 99 103 (Pubitemid 38314695)
107. Matsuo S., Nakamura Y., Matsui T., Matsumoto T., Kinoshita M. Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and Tl-201 SPECT imaging. Ann Nucl Med: 2001; 15 4 373 375 (Pubitemid 32899576)
108. Knapp W. H., Bentrup A., Ohlmeier H. Indium-111-labelled antimyosin antibody imaging in a patient with cardiac sarcoidosis. Eur J Nucl Med: 1993; 20 1 80 82 (Pubitemid 23015341)
109. Tahara N., Tahara A., Nitta Y., et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging: 2010; 3 12 1219 1228
110. Matthews R., Bench T., Meng H., Franceschi D., Relan N., Brown D. L. Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT. J Nucl Cardiol: 2012; 19 4 807 810
111. Nishiyama Y., Yamamoto Y., Fukunaga K., et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med: 2006; 47 10 1571 1576 (Pubitemid 47545019)
112. Braun J. J., Kessler R., Constantinesco A., Imperiale A. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging: 2008; 35 8 1537 1543
113. Teirstein A. S., Machac J., Almeida O., Lu P., Padilla M. L., Iannuzzi M. C. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest: 2007; 132 6 1949 1953
114. Mostard R. L., Verschakelen J. A., van Kroonenburgh M. J., et al. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med: 2013; 107 3 439 447
115. Mostard R. L., Vöö S., van Kroonenburgh M. J., et al. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med: 2011; 105 12 1917 1924
116. Keijsers R. G., Verzijlbergen E. J., van den Bosch J. M., et al. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis: 2011; 28 2 123 129
117. Sobic-Saranovic D., Artiko V., Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med: 2013; 43 6 404 411
118. Okumura W., Iwasaki T., Toyama T., et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med: 2004; 45 12 1989 1998 (Pubitemid 47611626)
119. Blankstein R., Osborne M., Naya M., et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol: 2014; 63 4 329 336
120. Schatka I., Bengel F. M. Advanced imaging of cardiac sarcoidosis. J Nucl Med: 2014; 55 1 99 106
121. Ishimaru S., Tsujino I., Takei T., et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J: 2005; 26 15 1538 1543 (Pubitemid 41373496)
122. Okumura W., Iwasaki T., Ueda T., et al. Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis. Kaku igaku Jpn J Nucl Med: 1999; 36 341 348 (Pubitemid 29318390)
123. Yamagishi H., Shirai N., Takagi M., et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med: 2003; 44 7 1030 1036 (Pubitemid 39663376)
124. Takeda N., Yokoyama I., Hiroi Y., et al. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation: 2002; 105 9 1144 1145 (Pubitemid 34212627)
125. Ohira H., Tsujino I., Ishimaru S., et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging: 2008; 35 5 933 941
126. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol: 2005; 184 1 249 254 (Pubitemid 40040938)
127. Giesbrandt K. J., Bolan C. W., Shapiro B. P., Edwards W. D., Mergo P. J. Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. AJR Am J Roentgenol: 2013; 200 3 W274 82
128. Ordovas K. G., Higgins C. B. Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology: 2011; 261 2 358 374
129. Serra J. J., Monte G. U., Mello E. S., et al. Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation: 2003; 107 20 e188 e189s
130. Chandra M., Silverman M. E., Oshinski J., Pettigrew R. Diagnosis of cardiac sarcoidosis aided by MRI. Chest: 1996; 110 2 562 565 (Pubitemid 26269295)
131. Shimada T., Shimada K., Sakane T., et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med: 2001; 110 7 520 527
132. Doherty M. J., Kumar S. K., Nicholson A. A., McGivern D. V. Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment. Respir Med: 1998; 92 4 697 699 (Pubitemid 28174845)
133. Eliasch H., Juhlin-Dannfelt A., Sjögren I., Terent A. Magnetic resonance imaging as an aid to the diagnosis and treatment evaluation of suspected myocardial sarcoidosis in a fighter pilot. Aviat Space Environ Med: 1995; 66 10 1010 1013
134. Matsuki M., Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol: 2000; 55 4 323 325 (Pubitemid 32054524)
135. Bajaj A. K., Kopelman H. A., Echt D. S. Cardiac sarcoidosis with sudden death: treatment with the automatic implantable cardioverter defibrillator. Am Heart J: 1988; 116 2 Pt 1 557 560
136. Danias P. G. Gadolinium-enhanced cardiac magnetic resonance imaging: expanding the spectrum of clinical applications. Am J Med: 2001; 110 7 591 592
137. Vignaux O., Dhote R., Duboc D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest: 2002; 122 6 1895 1901 (Pubitemid 36051121)
138. Smedema J. P., Snoep G., van Kroonenburgh M. P., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol: 2005; 45 10 1683 1690 (Pubitemid 40704507)
139. Ichinose A., Otani H., Oikawa M., et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol: 2008; 191 3 862 869
140. Matoh F., Satoh H., Shiraki K., et al. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Cardiol: 2008; 51 3 179 188 (Pubitemid 351718494)
141. Watanabe E., Kimura F., Nakajima T., et al. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging: 2013; 28 1 60 66
142. Yoshida A., Ishibashi-Ueda H., Yamada N., et al. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Eur J Heart Fail: 2013; 15 2 166 175
143. Cheong B. Y., Muthupillai R., Nemeth M., et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis: 2009; 26 1 39 46
144. Ishibashi K., Takeda M., Yamahara Y. Clinical utility of a magnetic resonance-conditional pacemaker in a patient with cardiac sarcoidosis. Intern Med: 2013; 52 12 1341 1345
145. Shafee M. A., Fukuda K., Wakayama Y., et al. Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis. J Cardiol: 2012; 60 6 448 453
146. Wilkoff B. L., Bello D., Taborsky M., et al. EnRhythm MRI SureScan Pacing System Study Investigators. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm: 2011; 8 1 65 73
147. Stevens S. M., Tung R., Rashid S., et al. Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter- defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. Heart Rhythm: 2014; 11 2 289 298
148. Ishikawa T., Kondoh H., Nakagawa S., Koiwaya Y., Tanaka K. Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest: 1984; 85 3 445 447 (Pubitemid 14160392)
149. Lorell B., Alderman E. L., Mason J. W. Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol: 1978; 42 1 143 146 (Pubitemid 8387798)
150. Uemura A., Morimoto S., Hiramitsu S., Kato Y., Ito T., Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J: 1999; 138 2 Pt 1 299 302 (Pubitemid 29379681)
151. Ratner S. J., Fenoglio J. J. Jr, Ursell P. C. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest: 1986; 90 4 528 533 (Pubitemid 17191564)
152. Felker G. M., Hu W., Hare J. M., Hruban R. H., Baughman K. L., Kasper E. K. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore): 1999; 78 4 270 283 (Pubitemid 29343203)
153. Veinot J. P. Diagnostic endomyocardial biopsy pathology: secondary myocardial diseases and other clinical indications - a review. Can J Cardiol: 2002; 18 3 287 296 (Pubitemid 34411244)
154. Basso C., Thiene G., Corrado D., Angelini A., Nava A., Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation: 1996; 94 5 983 991 (Pubitemid 26292851)
155. Dechering D. G., Kochhäuser S., Wasmer K., et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm: 2013; 10 2 158 164
156. Choo W. K., Denison A. R., Miller D. R., Dempsey O. J., Dawson D. K., Broadhurst P. A. Cardiac sarcoid or arrhythmogenic right ventricular cardiomyopathy: a role for positron emission tomography (PET)? J Nucl Cardiol: 2013; 20 3 479 480
157. Litovsky S. H., Burke A. P., Virmani R. Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells. Mod Pathol: 1996; 9 12 1126 1134 (Pubitemid 27023591)
158. Okura Y., Dec G. W., Hare J. M., et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol: 2003; 41 2 322 329
159. Yoshizawa S., Kato T. S., Mancini D., Marboe C. C. Outcome of patients having heart transplantation for lymphocytic myocarditis. Am J Cardiol: 2013; 112 3 405 410
160. Mavrogeni S., Sfikakis P. P., Gialafos E., et al. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken): 2014; 66 1 104 112
161. Kang E. J., Kim S. M., Choe Y. H., Lee G. Y., Lee K. N., Kim D. K. Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta. Radiology: 2014; 270 1 74 81
162. Miszalski-Jamka T., Szczeklik W., Sokołowska B., et al. Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener's) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging: 2013; 29 4 843 853
163. Mohty D., Damy T., Cosnay P., et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis: 2013; 106 10 528 540
164. Marques N., Gan V. C., Leo Y. S. Dengue myocarditis in Singapore: two case reports. Infection: 2013; 41 3 709 714
165. Nunes M. C., Dones W., Morillo C. A., Encina J. J., Ribeiro A. L.;
166. Homsi M., Alsayed L., Safadi B., Mahenthiran J., Das M. K. Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Ann Noninvasive Electrocardiol: 2009; 14 4 319 326
167. Takagi M., Yokoyama Y., Aonuma K., Aihara N., Hiraoka M.; Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan. J Cardiovasc Electrophysiol: 2007; 18 12 1244 1251 (Pubitemid 350115786)
168. Priori S. G., Gasparini M., Napolitano C., et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol: 2012; 59 1 37 45
169. Catalano O., Antonaci S., Moro G., et al. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J: 2009; 30 18 2241 2248
170. Quarta G., Husain S. I., Flett A. S., et al. Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance. J Cardiovasc Magn Reson: 2013; 15 16
171. Steckman D. A., Schneider P. M., Schuller J. L., et al. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol: 2012; 110 4 575 579
172. Mehta D., Lubitz S. A., Frankel Z., et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest: 2008; 133 6 1426 1435 (Pubitemid 351893001)
173. Mehta D., Mori N., Goldbarg S. H., Lubitz S., Wisnivesky J. P., Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol: 2011; 4 1 43 48
174. Uusimaa P., Ylitalo K., Anttonen O., et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace: 2008; 10 6 760 766 (Pubitemid 351775278)
175. Kato Y., Morimoto S., Uemura A., Hiramitsu S., Ito T., Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis: 2003; 20 2 133 137 (Pubitemid 36841694)
176. Pierre-Louis B., Prasad A., Frishman W. H. Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol Rev: 2009; 17 4 153 158
177. Sadek M. M., Yung D., Birnie D. H., Beanlands R. S., Nery P. B. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol: 2013; 29 9 1034 1041
178. Grutters J. C., van den Bosch J. M. Corticosteroid treatment in sarcoidosis. Eur Respir J: 2006; 28 3 627 636 (Pubitemid 44794680)
179. Baughman R. P., Culver D. A., Judson M. A. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med: 2011; 183 5 573 581
180. Sugisaki K., Yamaguchi T., Nagai S., et al. Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis: 2003; 20 3 222 226 (Pubitemid 37351544)
181. Yodogawa K., Seino Y., Ohara T., Takayama H., Katoh T., Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol: 2011; 16 2 140 147
182. Yodogawa K., Seino Y., Shiomura R., et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol: 2013; 62 5 320 325
183. Stees C. S., Khoo M. S., Lowery C. M., Sauer W. H. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol: 2011; 22 2 210 213
184. Hiramastu S., Tada H., Naito S., Oshima S., Taniguchi K. Steroid treatment deteriorated ventricular tachycardia in a patient with right ventricle-dominant cardiac sarcoidosis. Int J Cardiol: 2009; 132 2 e85 e87
185. Lazar C. A., Culver D. A. Treatment of sarcoidosis. Semin Respir Crit Care Med: 2010; 31 4 501 518
186. Wang T., Weigt S. S., Belperio J. A., Lynch J. P. III. Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring. Semin Respir Crit Care Med: 2011; 32 3 346 370
187. Lynch J. P. III, McCune W. J. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med: 1997; 155 2 395 420 (Pubitemid 27085778)
188. Demeter S. L. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest: 1988; 94 1 202 203
189. Barnabe C., McMeekin J., Howarth A., Martin L. Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol: 2008; 35 8 1686 1687
190. Uthman I., Touma Z., Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol: 2007; 26 11 2001 2003 (Pubitemid 47516998)
191. Mezaki T., Chinushi M., Washizuka T., et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med: 2001; 40 8 731 735 (Pubitemid 33614005)
192. Huang P. L., Brooks R., Carpenter C., Garan H. Antiarrhythmic therapy guided by programmed electrical stimulation in cardiac sarcoidosis with ventricular tachycardia. Am Heart J: 1991; 121 2 Pt 1 599 601
193. Kowey P. R., Waxman H. L., Greenspon A., et al. Philadelphia Arrhythmia Group. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Am J Cardiol: 1990; 65 9 594 598 (Pubitemid 20091885)
194. Poll D. S., Marchlinski F. E., Buxton A. E., Josephson M. E. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol: 1986; 58 10 992 997 (Pubitemid 17175840)
195. Shabetai R. Sarcoidosis and the heart. Curr Treat Options Cardiovasc Med: 2000; 2 5 385 398
196. Stein E., Jackler I., Stimmel B., Stein W., Siltzbach L. E. Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J: 1973; 86 4 474 477
197. Takada K., Ina Y., Yamamoto M., Satoh T., Morishita M. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis: 1994; 11 2 113 117 (Pubitemid 24311240)
198. Paz H. L., McCormick D. J., Kutalek S. P., Patchefsky A. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest: 1994; 106 5 1603 1607 (Pubitemid 24346140)
199. Betensky B. P., Tschabrunn C. M., Zado E. S., et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter- defibrillators. Heart Rhythm: 2012; 9 6 884 891
200. Chinushi M., Mezaki T., Aoki Y., Nakagawa I., Washizuka T., Aizawa Y. Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis. Jpn Circ J: 2000; 64 8 635 637
201. Epstein A. E., DiMarco J. P., Ellenbogen K. A., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol: 2008; 51 21 e1 e62 (Pubitemid 351689050)
202. Kron J., Sauer W., Schuller J., et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace: 2013; 15 3 347 354
203. Koplan B. A., Soejima K., Baughman K., Epstein L. M., Stevenson W. G. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm: 2006; 3 8 924 929 (Pubitemid 44103499)
204. Jefic D., Joel B., Good E., et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm: 2009; 6 2 189 195
205. Harris I. M., Guarino R. Cardiac sarcoidosis: a new approach to treatment. Cardiovasc Surg: 1994; 2 3 420 422 (Pubitemid 24167769)
206. Chang T. I., Chi N. H., Chou N. K., et al. Isolated cardiac sarcoidosis in heart transplantation. Transplant Proc: 2012; 44 4 903 906
207. Perkel D., Czer L. S., Morrissey R. P., et al. Heart transplantation for end-stage heart failure due to cardiac sarcoidosis. Transplant Proc: 2013; 45 6 2384 2386
208. Milman N., Andersen C. B., Mortensen S. A., Sander K. Cardiac sarcoidosis and heart transplantation: a report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis: 2008; 25 1 51 59
209. Akashi H., Kato T. S., Takayama H., et al. Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation-single-center retrospective analysis. J Cardiol: 2012; 60 5 407 410
210. Donsky A. S., Escobar J., Capehart J., Roberts W. C. Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol: 2002; 89 12 1447 1450 (Pubitemid 34607795)
211. Zaidi A. R., Zaidi A., Vaitkus P. T. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant: 2007; 26 7 714 717 (Pubitemid 47001719)
212. Oni A. A., Hershberger R. E., Norman D. J., et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant: 1992; 11 2 Pt 1 367 369
213. Khan R., Tweedie E. J., Pflugfelder P. W., White J. A. Cardiac sarcoid in a heart transplant recipient: detection with cardiac magnetic resonance imaging. Transplant Proc: 2010; 42 5 1976 1978
214. Luk A., Lee A., Ahn E., Soor G. S., Ross H. J., Butany J. Cardiac sarcoidosis: recurrent disease in a heart transplant patient following pulmonary tuberculosis infection. Can J Cardiol: 2010; 26 7 e273 e275
215. Yager J. E., Hernandez A. F., Steenbergen C., et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant: 2005; 24 11 1988 1990 (Pubitemid 41641881)
216. Langah R., Spicer K., Gebregziabher M., Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol: 2009; 16 5 801 810